Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

Completed · Phase 2

Conditions studied: Cervical Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of bryostatin-1 plus cisplatin in treating patients who have recurrent or advanced cancer of the cervix.

Key facts

Study ID

NCT00005965

Run by

Icahn School of Medicine at Mount Sinai

Starts

2000-08-01

Expected to finish

2004-04-01

Last updated by the study team

2013-07-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Saint Vincent Catholic Medical Center of New York — New York, New York, United States
• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• New York Presbyterian Hospital - Cornell Campus — New York, New York, United States
• Mount Sinai Medical Center, NY — New York, New York, United States
• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• New York Medical College — Valhalla, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.